Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study

Up to date, human urotensin II (UII) is the most potent vasoconstrictor in mammalian animals. To explore whether UII played an important role in the development of hypertension, we conducted a prospective study in Changshu city, China. The baseline investigation was carried out in 2007, and the firs...

Full description

Saved in:
Bibliographic Details
Main Authors: Huijian Xie, Xinya Wang, Yan He, Daoyi Huang, Xinyuan Qu, Yanbo Jiang, Yan An, Shaoyan Zhang, Mingzhi Zhang
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2020/3284769
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849415099900493824
author Huijian Xie
Xinya Wang
Yan He
Daoyi Huang
Xinyuan Qu
Yanbo Jiang
Yan An
Shaoyan Zhang
Mingzhi Zhang
author_facet Huijian Xie
Xinya Wang
Yan He
Daoyi Huang
Xinyuan Qu
Yanbo Jiang
Yan An
Shaoyan Zhang
Mingzhi Zhang
author_sort Huijian Xie
collection DOAJ
description Up to date, human urotensin II (UII) is the most potent vasoconstrictor in mammalian animals. To explore whether UII played an important role in the development of hypertension, we conducted a prospective study in Changshu city, China. The baseline investigation was carried out in 2007, and the first follow-up investigation was conducted in 2013. From the participants, we randomly obtained 2000 normotensive subjects aged 40 years and older without any severe disease at baseline and examined plasma UII and endothelin-1 (ET-1) with their blood samples at baseline. Logistic models were used to analyze the association between baseline UII, baseline ET-1, and newly occurring hypertension. In 1,819 subjects with complete data, 723 subjects developed into hypertensive in about five years. After adjusting some potential confounders, the odds ratio (95% confidence interval) for risk of hypertension comparing the highest with the lowest quartile of baseline UII was 0.888 (0.689–1.144). The role of UII in the development of hypertension was not found in the current study; therefore, further research studies should be conducted to explore the relationship between UII and hypertension.
format Article
id doaj-art-58a8237d673f4e3fbf144fd014a493a1
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-58a8237d673f4e3fbf144fd014a493a12025-08-20T03:33:38ZengWileyInternational Journal of Hypertension2090-03842090-03922020-01-01202010.1155/2020/32847693284769Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective StudyHuijian Xie0Xinya Wang1Yan He2Daoyi Huang3Xinyuan Qu4Yanbo Jiang5Yan An6Shaoyan Zhang7Mingzhi Zhang8Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaMacrostat (China) Clinical Research Co., Ltd., Shanghai 200120, ChinaDepartment of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaDepartment of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaDepartment of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaDepartment of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaDepartment of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaDepartment of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaDepartment of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou 215123, ChinaUp to date, human urotensin II (UII) is the most potent vasoconstrictor in mammalian animals. To explore whether UII played an important role in the development of hypertension, we conducted a prospective study in Changshu city, China. The baseline investigation was carried out in 2007, and the first follow-up investigation was conducted in 2013. From the participants, we randomly obtained 2000 normotensive subjects aged 40 years and older without any severe disease at baseline and examined plasma UII and endothelin-1 (ET-1) with their blood samples at baseline. Logistic models were used to analyze the association between baseline UII, baseline ET-1, and newly occurring hypertension. In 1,819 subjects with complete data, 723 subjects developed into hypertensive in about five years. After adjusting some potential confounders, the odds ratio (95% confidence interval) for risk of hypertension comparing the highest with the lowest quartile of baseline UII was 0.888 (0.689–1.144). The role of UII in the development of hypertension was not found in the current study; therefore, further research studies should be conducted to explore the relationship between UII and hypertension.http://dx.doi.org/10.1155/2020/3284769
spellingShingle Huijian Xie
Xinya Wang
Yan He
Daoyi Huang
Xinyuan Qu
Yanbo Jiang
Yan An
Shaoyan Zhang
Mingzhi Zhang
Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study
International Journal of Hypertension
title Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study
title_full Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study
title_fullStr Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study
title_full_unstemmed Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study
title_short Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study
title_sort association between plasma urotensin ii and risk of hypertension findings from a prospective study
url http://dx.doi.org/10.1155/2020/3284769
work_keys_str_mv AT huijianxie associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT xinyawang associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT yanhe associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT daoyihuang associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT xinyuanqu associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT yanbojiang associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT yanan associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT shaoyanzhang associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy
AT mingzhizhang associationbetweenplasmaurotensiniiandriskofhypertensionfindingsfromaprospectivestudy